Cargando…
Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China
BACKGROUND: Dyslipidemia is a predisposing factor for coronary heart disease (CHD). High-intensity statin therapy is recommended as secondary prevention. ABCB1 and SLCO1B1 genes influence the efficacy and safety of statins. Xinjiang is a multi-ethnic area; however, little is known about the prevalen...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466639/ https://www.ncbi.nlm.nih.gov/pubmed/34563206 http://dx.doi.org/10.1186/s12944-021-01544-3 |
_version_ | 1784573193101508608 |
---|---|
author | Wang, Tingting Sun, Li Xu, Li Zhao, Ting Feng, Jie Yu, Luhai Wu, Jianhua Li, Hongjian |
author_facet | Wang, Tingting Sun, Li Xu, Li Zhao, Ting Feng, Jie Yu, Luhai Wu, Jianhua Li, Hongjian |
author_sort | Wang, Tingting |
collection | PubMed |
description | BACKGROUND: Dyslipidemia is a predisposing factor for coronary heart disease (CHD). High-intensity statin therapy is recommended as secondary prevention. ABCB1 and SLCO1B1 genes influence the efficacy and safety of statins. Xinjiang is a multi-ethnic area; however, little is known about the prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in minority groups with CHD. OBJECTIVE: To measure levels of lipid and apolipoprotein and the prevalence of dyslipidemia and gene polymorphisms of ABCB1, SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with CHD in Xinjiang. METHODS: This descriptive retrospective study compares lipid levels in ethnic groups using Kruskal-Wallis test or analysis of variance. The study compared gene polymorphisms and the prevalence of dyslipidemia among different ethnic groups using the chi-square test. The lipid profiles in plasma were measured before lipid-lowering therapy using commercially available kits. Genotyping of SLCO1B1 and ABCB1 variants was performed using sequencing by hybridization. RESULTS: A total of 2218 patients were successfully screened, including 1044 Han, 828 Uygur, 113 Kazak, 138 Hui, 39 Tatar, 36 Kirgiz, and 20 Sibe patients. The overall mean age was 61.8 ± 10.8 years, and 72.5% of participants were male. Dyslipidemia prevalence in these ethnic groups was 42.1, 49.8, 52.2, 40.6, 48.7, 41.7, and 45.0%, respectively. The prevalence of dyslipidemia, high total cholesterol (TC), high triglycerides (TG), and high low density lipoprotein cholesterol (LDL-C) differed significantly among the groups (P = 0.024; P < 0.001; P < 0.001; P < 0.001, respectively). For the Han group, high LDL-C, high TC, and high TG prevalence differed significantly by gender (P = 0.001, P = 0.022, P = 0.037, respectively). The prevalence of high TC, high TG, and low high density lipoprotein cholesterol (HDL-C) differed significantly by gender in the Uygur group (P = 0.006, P = 0.004, P < 0.001, respectively). The prevalence of high TC in Hui patients significantly differed by gender (P = 0.043). These findings suggest that polymorphisms in ABCB1 and C3435T differ significantly across ethnicities (P < 0.001). CONCLUSIONS: The prevalences of dyslipidemia, high TC, high TG, and high LDL-C in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe CHD patients in Xinjiang differed concerning ethnicity. Ethnic, gender, and lifestyle were the key factors that affected the lipid levels of the population. The prevalence of polymorphisms of ABCB1 and C3435T significantly differed across ethnicities. These findings will aid the selection of precision lipid-lowering medications and prevention and treatment of CHD according to ethnicity in Xinjiang. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01544-3. |
format | Online Article Text |
id | pubmed-8466639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84666392021-09-27 Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China Wang, Tingting Sun, Li Xu, Li Zhao, Ting Feng, Jie Yu, Luhai Wu, Jianhua Li, Hongjian Lipids Health Dis Research BACKGROUND: Dyslipidemia is a predisposing factor for coronary heart disease (CHD). High-intensity statin therapy is recommended as secondary prevention. ABCB1 and SLCO1B1 genes influence the efficacy and safety of statins. Xinjiang is a multi-ethnic area; however, little is known about the prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in minority groups with CHD. OBJECTIVE: To measure levels of lipid and apolipoprotein and the prevalence of dyslipidemia and gene polymorphisms of ABCB1, SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with CHD in Xinjiang. METHODS: This descriptive retrospective study compares lipid levels in ethnic groups using Kruskal-Wallis test or analysis of variance. The study compared gene polymorphisms and the prevalence of dyslipidemia among different ethnic groups using the chi-square test. The lipid profiles in plasma were measured before lipid-lowering therapy using commercially available kits. Genotyping of SLCO1B1 and ABCB1 variants was performed using sequencing by hybridization. RESULTS: A total of 2218 patients were successfully screened, including 1044 Han, 828 Uygur, 113 Kazak, 138 Hui, 39 Tatar, 36 Kirgiz, and 20 Sibe patients. The overall mean age was 61.8 ± 10.8 years, and 72.5% of participants were male. Dyslipidemia prevalence in these ethnic groups was 42.1, 49.8, 52.2, 40.6, 48.7, 41.7, and 45.0%, respectively. The prevalence of dyslipidemia, high total cholesterol (TC), high triglycerides (TG), and high low density lipoprotein cholesterol (LDL-C) differed significantly among the groups (P = 0.024; P < 0.001; P < 0.001; P < 0.001, respectively). For the Han group, high LDL-C, high TC, and high TG prevalence differed significantly by gender (P = 0.001, P = 0.022, P = 0.037, respectively). The prevalence of high TC, high TG, and low high density lipoprotein cholesterol (HDL-C) differed significantly by gender in the Uygur group (P = 0.006, P = 0.004, P < 0.001, respectively). The prevalence of high TC in Hui patients significantly differed by gender (P = 0.043). These findings suggest that polymorphisms in ABCB1 and C3435T differ significantly across ethnicities (P < 0.001). CONCLUSIONS: The prevalences of dyslipidemia, high TC, high TG, and high LDL-C in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe CHD patients in Xinjiang differed concerning ethnicity. Ethnic, gender, and lifestyle were the key factors that affected the lipid levels of the population. The prevalence of polymorphisms of ABCB1 and C3435T significantly differed across ethnicities. These findings will aid the selection of precision lipid-lowering medications and prevention and treatment of CHD according to ethnicity in Xinjiang. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01544-3. BioMed Central 2021-09-25 /pmc/articles/PMC8466639/ /pubmed/34563206 http://dx.doi.org/10.1186/s12944-021-01544-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Tingting Sun, Li Xu, Li Zhao, Ting Feng, Jie Yu, Luhai Wu, Jianhua Li, Hongjian Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China |
title | Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China |
title_full | Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China |
title_fullStr | Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China |
title_full_unstemmed | Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China |
title_short | Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China |
title_sort | prevalence of dyslipidemia and gene polymorphisms of abcb1 and slco1b1 in han, uygur, kazak, hui, tatar, kirgiz, and sibe populations with coronary heart disease in xinjiang, china |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466639/ https://www.ncbi.nlm.nih.gov/pubmed/34563206 http://dx.doi.org/10.1186/s12944-021-01544-3 |
work_keys_str_mv | AT wangtingting prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina AT sunli prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina AT xuli prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina AT zhaoting prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina AT fengjie prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina AT yuluhai prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina AT wujianhua prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina AT lihongjian prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina |